Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Gender dimorphic associations between N-terminal pro-brain natriuretic peptide, body mass index and blood pressure in children and adolescents.

Pervanidou P, Akalestos A, Sakka S, Kanaka-Gantenbein C, Papassotiriou I, Chrousos GP.

Horm Res Paediatr. 2010;73(5):341-8. doi: 10.1159/000308166. Epub 2010 Apr 14.

PMID:
20389104
2.

Associations between circulating N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) and adiponectin concentrations depend on obesity level in female adolescents: gender dimorphic findings.

Pervanidou P, Margeli A, Akalestos A, Sakka S, Kanaka-Gantenbein C, Papassotiriou I, Chrousos GP.

Horm Metab Res. 2009 Nov;41(11):829-33. doi: 10.1055/s-0029-1233459. Epub 2009 Aug 10.

PMID:
19670155
3.
4.

Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr.

Am Heart J. 2005 Apr;149(4):744-50.

PMID:
15990762
5.

Impact of body mass index on plasma N-terminal ProB-type natriuretic peptides in Chinese atrial fibrillation patients without heart failure.

Zheng LH, Wu LM, Yao Y, Chen WS, Bao JR, Huang W, Shi R, Zhang KJ, Zhang S.

PLoS One. 2014 Aug 21;9(8):e105249. doi: 10.1371/journal.pone.0105249. eCollection 2014.

6.

Early cardiac abnormalities and serum N-terminal pro B-type natriuretic peptide levels in obese children.

Battal F, Ermis B, Aktop Z, Can M, Demirel F.

J Pediatr Endocrinol Metab. 2011;24(9-10):723-6.

PMID:
22145463
7.
8.

Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.

Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, Santaló M, Pinto YM, Januzzi JL Jr.

Arch Intern Med. 2007 Feb 26;167(4):400-7.

PMID:
17325303
9.

Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.

Christenson RH, Azzazy HM, Duh SH, Maynard S, Seliger SL, Defilippi CR.

Clin Chem. 2010 Apr;56(4):633-41. doi: 10.1373/clinchem.2009.129742. Epub 2010 Feb 18.

10.

Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.

Nadrowski P, Chudek J, Grodzicki T, Mossakowska M, Skrzypek M, Wiecek A, Zdrojewski T, Kozakiewicz K.

Exp Gerontol. 2013 Sep;48(9):852-7. doi: 10.1016/j.exger.2013.05.060. Epub 2013 Jun 13.

PMID:
23770107
11.

N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity.

Mangge H, Almer G, Zelzer S, Vasan R, Kraigher-Krainer E, Gasser R, Schnedl W, Ille R, Wallner S, Möller R, Horejsi R, Weghuber D.

Clin Chem Lab Med. 2011 Sep;49(9):1539-45. doi: 10.1515/CCLM.2011.627. Epub 2011 Jun 10.

PMID:
21663466
12.

Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.

Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH Jr, de Lemos JA.

Circulation. 2005 Oct 4;112(14):2163-8.

PMID:
16203929
13.

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity.

Fernandes F, Ramires FJ, Buck PC, Almeida IJ, Rabelo R, Dantas SA, Salemi VM, Halpern A, Mady C.

Braz J Med Biol Res. 2007 Feb;40(2):153-8.

14.

Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.

Cortés R, Otero MR, Morillas P, Roselló-Lletí E, Grigorian L, Martínez-Dolz L, de Burgos FG, Calabuig JR, Soria F, Lozano T, Portolés M, Bertomeu V.

Am J Hypertens. 2008 Jul;21(7):820-5. doi: 10.1038/ajh.2008.173. Epub 2008 Apr 24.

PMID:
18443568
15.

Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.

Miyagawa Y, Tominaga Y, Toda N, Takemura N.

Vet J. 2013 Aug;197(2):445-50. doi: 10.1016/j.tvjl.2013.02.016. Epub 2013 Apr 6.

PMID:
23570775
16.
17.

[Factors associated plasma B type natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels].

Chen Y, Yao CL, Shimada T.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Sep;36(9):825-30. Chinese.

PMID:
19102867
18.

[Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI].

Alibay Y, Schmitt C, Beauchet A, Dubourg O, Alexandre JA, Boileau C, Jondeau G, Puy H.

Ann Biol Clin (Paris). 2005 Jan-Feb;63(1):43-9. French.

19.

Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.

Alibay Y, Beauchet A, El Mahmoud R, Schmitt C, Brun-Ney D, Benoit MO, Dubourg O, Boileau C, Jondeau G, Puy H.

Biomed Pharmacother. 2005 Jan-Feb;59(1-2):20-4. Epub 2005 Jan 20.

PMID:
15740931

Supplemental Content

Support Center